Google Custom Search
Podcast Advocacy 2014 HBV Meeting navigation menu


PA Biotech
Liver Cancer Connect
Visit our Baruch Blumberg Institute of Living Science
World Hepatitis Alliance Member
HepB United

Top Stories    

*Please Note: Links to full articles may expire after 2 weeks. If you are unable to access the page via the links below, try searching the HBV Research List Archives at



Anti-viral Regimens Did Not Increase Risk for Renal Effects in HBV
Jan 26 – Anti-viral therapy did not increase the risk for renal disease among patients with hepatitis B, with or without renal risk factors before treatment, according to study data. Read more.

NIH Announces Funding for New Technologies for Viral Hepatitis
Jan 26 – The National Institutes of Health (NIH) has issued a funding opportunity announcement to encourage small businesses to address viral hepatitis research opportunities delineated in the Viral Hepatitis Action Plan. Read more.

Livers Kept Healthier for Transplant by New Machine-Perfusion Organ Preservation System
Jan 26 – A new preservation system that pumps cooled, oxygen-rich fluid into donor livers not only keeps the organs in excellent condition for as long as nine hours before transplantation, but also leads to dramatically better liver function and increases survival of recipients, according to a series of animal studies by researchers. Read more.

Sugar Is Super Deadly 
Jan 26 –So you are a sugar addict, but do you know what this ingredient is doing to your liver and your health? Read more.

Falling Through the Cracks: Mothers With Hepatitis B Receive Inadequate Treatment, Follow-up
Jan 19 – More than one-third of women with the hepatitis B virus are initially diagnosed with the infection at their first prenatal care visit, but they do not receive follow-up care for the infection after their pregnancy, researchers have found. Read more.

FDA Orders Partial Hold on Arrowhead HBV Drug Trial
Jan 19 – Arrowhead Research this week announced that the US Food and Drug Administration ordered a partial hold on a planned Phase IIb trial of ARC-520, the company's RNAi-based drug candidate for hepatitis B. Read more.

Cancer 'Bad Luck' Theory Strongly Questioned by WHO Specialized Agency
Jan 19 – The International Agency for Research on Cancer (IARC), WHO’s specialized cancer agency, strongly disagrees with the recent scientific report suggesting random mutations, or “bad luck” as the major contributor to cancer overall.  Hepatitis B is highlighted with declines in liver cancer noted in countries with increased hepatitis B vaccination rates. Read more.

Scientists Claim Coffee Protects Our Liver
Jan 19 – The results of the recent study suggest that two cups of coffee per day can lower risk of death from liver cirrhosis by 60%, with the exception of cirrhosis caused by the hepatitis B virus infection. Read more.

Hepatitis B Patients Benefit from New Co-Payment Assistance
Jan 12Patient Advocate Foundation is pleased to announce the addition of a new assistance fund to their Co-Pay Relief program dedicated to assisting insured Hepatitis B patients with out of pocket pharmaceutical expenses. Read more.

Canada's Tekmira to Buy U.S.-Based OnCore Biopharma, Focus on HBV Treatment
Jan 12 – Canada's Tekmira Pharmaceuticals Corp agreed to buy Pennsylvania-based OnCore Biopharma Inc to focus on developing hepatitis B virus treatment by combining multiple therapeutic methods. Read more.

Viral Hepatitis Prevention Coordinators, a Vital CDC Program Helping to Achieve the Goals of the Viral Hepatitis Action Plan
Jan 12 – Viral Hepatitis Prevention Coordinators (VHPCs) are vital to the implementation of the nation’s Action Plan for the Prevention, Care, & Treatment of Viral Hepatitis, and ultimately, achievement of 3 of the national goals of reducing viral hepatitis transmission and disease. Read more.

Ugandan Govt Urged on Hepatitis B, the Forgotten Killer
Jan 12 – People living with hepatitis B have urged the Ugandan government to adopt policies and guidelines to fight the disease, whose spread is reportedly on the rise. Read more.

Neonatal HBV Vaccination Reduces the Risk of Liver Cancer and Other Liver Diseases in Young Adults in China
Jan 5 – Neonatal HBV vaccination reduces the risk of liver cancer and other liver diseases in young adults in China, according to a study based on long-term outcomes from a large, randomized controlled study. Read more.

Two-Thirds of Adult Cancers Largely Due to Bad Luck
Jan 5 – A new statistical model created by Johns Hopkins researchers may help measure the proportion of cancers caused by random mutations during stem cell division versus those related to environmental factors and heredity. Liver cancer incidence appeared to be a combination of both, as it is often associated with viral hepatitis. Read more.

Liver Cirrhosis More Common Than Previously Thought
Jan 5 – Cirrhosis of the liver is more common than previously thought, affecting more than 633,000 adults yearly, according to a study published in the Journal of Clinical Gastroenterology. Read more.

ILBS Designated as WHO Collaborating Centre on Viral Hepatitis
Jan 5 – The Institute of Liver and Biliary Sciences (ILBS) has been designated as a WHO Collaborating Centre (WHOCC) on viral hepatitis and liver diseases.  Asia houses over 75% of hepatitis B and C and liver cancer cases, and India has close to 60 million such patients. Read more.



Archived News Stories

*Please Note: Links to archived articles may have expired. If you are unable to access the page via the links below, try searching the HBV Research List Archives at

ARCHIVES: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

amazon smile

Connect with Us

facebook twitter youtube linkedin
Hep B Blog
Crystal Ball Gala
Bookmark and Share
Site design by Ferguson Lynch  FL logo